Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

Similar articles for PubMed (Select 9573295)

1.

Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes.

Ponnazhagan S, Weigel KA, Raikwar SP, Mukherjee P, Yoder MC, Srivastava A.

J Virol. 1998 Jun;72(6):5224-30.

2.
3.

A review of blood diseases and cytopenias associated with human parvovirus B19 infection.

Kerr JR.

Rev Med Virol. 2015 May 11. doi: 10.1002/rmv.1839. [Epub ahead of print]

PMID:
25962796
4.

The role of parvovirus B19 and the immune response in the pathogenesis of acute leukemia.

Kerr JR, Mattey DL.

Rev Med Virol. 2015 May;25(3):133-55. doi: 10.1002/rmv.1830. Epub 2015 Apr 8.

PMID:
25855476
5.

Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.

Schön C, Biel M, Michalakis S.

Eur J Pharm Biopharm. 2015 Jan 20. pii: S0939-6411(15)00012-0. doi: 10.1016/j.ejpb.2015.01.009. [Epub ahead of print]

PMID:
25615882
6.
7.

Parvovirus infection-induced DNA damage response.

Luo Y, Qiu J.

Future Virol. 2013 Mar 1;8(3):245-257.

8.

In vitro encapsulation of heterologous dsDNA into human parvovirus B19 virus-like particles.

Sánchez-Rodríguez SP, Enrriquez-Avila JV, Soto-Fajardo JM, Peña-Montes C, Bustos-Jaimes I.

Mol Biotechnol. 2015 Apr;57(4):309-17. doi: 10.1007/s12033-014-9823-4.

PMID:
25389040
9.

Enhanced transgene expression from recombinant single-stranded D-sequence-substituted adeno-associated virus vectors in human cell lines in vitro and in murine hepatocytes in vivo.

Ling C, Wang Y, Lu Y, Wang L, Jayandharan GR, Aslanidi GV, Li B, Cheng B, Ma W, Lentz T, Ling C, Xiao X, Samulski RJ, Muzyczka N, Srivastava A.

J Virol. 2015 Jan 15;89(2):952-61. doi: 10.1128/JVI.02581-14. Epub 2014 Oct 29.

PMID:
25355884
10.

Two-point resistance of a resistor network embedded on a globe.

Tan ZZ, Essam JW, Wu FY.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Jul;90(1):012130. Epub 2014 Jul 28.

PMID:
25122274
11.

Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions.

Basner-Tschakarjan E, Mingozzi F.

Front Immunol. 2014 Jul 23;5:350. doi: 10.3389/fimmu.2014.00350. eCollection 2014. Review.

12.

Gene expression analysis of potential genes and pathways involved in the pathogenic mechanisms of parvovirus B19 in human colorectal cancer.

Zhang WP, Yang H, Chen H, Zhu HR, Lei Q, Song YH, Dai ZM, Sun JS, Jiang LL, Nie ZG.

Oncol Lett. 2014 Aug;8(2):523-532. Epub 2014 May 16.

13.

Methods for the construction and propagation of recombinant adeno-associated virus vectors.

Bartlett JS, Samulski RJ.

Methods Mol Med. 1997;7:25-40. doi: 10.1385/0-89603-484-4:25.

PMID:
24493416
14.

Biosafety of recombinant adeno-associated virus vectors.

Dismuke DJ, Tenenbaum L, Samulski RJ.

Curr Gene Ther. 2013 Dec;13(6):434-52. Review.

PMID:
24195602
15.

Gene delivery via the hybrid vector of recombinant adeno-associated virus and polyethylenimine.

Hsu PY, Yang YW.

Eur J Pharm Sci. 2014 Feb 14;52:62-8. doi: 10.1016/j.ejps.2013.10.009. Epub 2013 Oct 29.

PMID:
24184196
16.

Human parvovirus B19 infection leads to downregulation of thyroid, estrogen, and retinoid hormone receptor expression.

Ignatovich IV, Hobbs JA.

Virology. 2013 Nov;446(1-2):173-9. doi: 10.1016/j.virol.2013.06.022. Epub 2013 Aug 28.

17.

Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.

Luo Y, Kleiboeker S, Deng X, Qiu J.

J Virol. 2013 Dec;87(23):12766-75. doi: 10.1128/JVI.02333-13. Epub 2013 Sep 18.

18.

Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.

Wolfisberg R, Ruprecht N, Kempf C, Ros C.

J Virol Methods. 2013 Oct;193(1):215-25. doi: 10.1016/j.jviromet.2013.06.003. Epub 2013 Jun 10.

PMID:
23764418
19.

Utility of vascular endothelial specific peptides for enhancement of adeno-associated virus-mediated gene transfer.

Merchan JA, Dean J, Azpurua F, Sen S, Zhu Y, Aikawa R.

Int J Biomed Sci. 2008 Sep;4(3):217-20.

20.

High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.

Song L, Li X, Jayandharan GR, Wang Y, Aslanidi GV, Ling C, Zhong L, Gao G, Yoder MC, Ling C, Tan M, Srivastava A.

PLoS One. 2013;8(3):e58757. doi: 10.1371/journal.pone.0058757. Epub 2013 Mar 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk